GB0030284D0 - Enzyme inhibitors - Google Patents

Enzyme inhibitors

Info

Publication number
GB0030284D0
GB0030284D0 GB0030284A GB0030284A GB0030284D0 GB 0030284 D0 GB0030284 D0 GB 0030284D0 GB 0030284 A GB0030284 A GB 0030284A GB 0030284 A GB0030284 A GB 0030284A GB 0030284 D0 GB0030284 D0 GB 0030284D0
Authority
GB
United Kingdom
Prior art keywords
enzyme inhibitors
inhibitors
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0030284A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Publication of GB0030284D0 publication Critical patent/GB0030284D0/en
Priority to CZ20023692A priority Critical patent/CZ296087B6/cs
Priority to SI200130744T priority patent/SI1286964T1/sl
Priority to MXPA02011079A priority patent/MXPA02011079A/es
Priority to JP2001582286A priority patent/JP4897179B2/ja
Priority to RU2002133222/04A priority patent/RU2294931C2/ru
Priority to PT01928117T priority patent/PT1286964E/pt
Priority to DE60129222T priority patent/DE60129222T2/de
Priority to CNB01812738XA priority patent/CN100358867C/zh
Priority to HU0302002A priority patent/HUP0302002A3/hu
Priority to AT01928117T priority patent/ATE366238T1/de
Priority to BR0110734-8A priority patent/BR0110734A/pt
Priority to EP01928117A priority patent/EP1286964B1/en
Priority to CA2408747A priority patent/CA2408747C/en
Priority to PL359671A priority patent/PL209780B1/pl
Priority to CN2007101010104A priority patent/CN101045715B/zh
Priority to ES01928117T priority patent/ES2288948T3/es
Priority to AU54981/01A priority patent/AU783615B2/en
Priority to KR1020027015132A priority patent/KR100812407B1/ko
Priority to IL15272101A priority patent/IL152721A0/xx
Priority to PCT/GB2001/002100 priority patent/WO2001085685A1/en
Priority to DK01928117T priority patent/DK1286964T3/da
Priority to US10/290,569 priority patent/US6872737B2/en
Priority to US10/917,175 priority patent/US7666885B2/en
Priority to AU2006200668A priority patent/AU2006200668B2/en
Priority to US11/788,755 priority patent/US7781463B2/en
Priority to CY20071101111T priority patent/CY1106826T1/el
Ceased legal-status Critical Current

Links

GB0030284A 2000-05-11 2000-12-12 Enzyme inhibitors Ceased GB0030284D0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
PL359671A PL209780B1 (pl) 2000-05-11 2001-05-11 Zastosowanie pochodnych tiadiazolidynodionu do wytwarzania leku
PCT/GB2001/002100 WO2001085685A1 (en) 2000-05-11 2001-05-11 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
CA2408747A CA2408747C (en) 2000-05-11 2001-05-11 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
MXPA02011079A MXPA02011079A (es) 2000-05-11 2001-05-11 Inhibidores heterociclicos de quinasa de sintasa de glucogeno gsk3.
JP2001582286A JP4897179B2 (ja) 2000-05-11 2001-05-11 グリコーゲンシンターゼキナーゼｇｓｋ−３の複素環インヒビター
RU2002133222/04A RU2294931C2 (ru) 2000-05-11 2001-05-11 Гетероциклические ингибиторы гликоген-синтазы киназы gsk-3
PT01928117T PT1286964E (pt) 2000-05-11 2001-05-11 Inibidores heterocíclicos da glicogénio sintase cinase gsk-3
DE60129222T DE60129222T2 (de) 2000-05-11 2001-05-11 Heterocyclischen inhibitoren von glycogen synthase kinase gsk-3
CNB01812738XA CN100358867C (zh) 2000-05-11 2001-05-11 糖原合酶激酶gsk-3的杂环抑制剂
HU0302002A HUP0302002A3 (en) 2000-05-11 2001-05-11 Heterocyclic inhibitors of glycogen synthase kinase gsk-3, their use and pharmaceutical compositions containing them
AT01928117T ATE366238T1 (de) 2000-05-11 2001-05-11 Heterocyclischen inhibitoren von glycogen synthase kinase gsk-3
BR0110734-8A BR0110734A (pt) 2000-05-11 2001-05-11 Inibidores heterocìclicos de cinase de sintase de glicogênio gsk-3
CN2007101010104A CN101045715B (zh) 2000-05-11 2001-05-11 糖原合酶激酶gsk-3的杂环抑制剂
CZ20023692A CZ296087B6 (cs) 2000-05-11 2001-05-11 Farmaceutický prostredek pro lécbu nemoci, na nízse podílí heterocyklické inhibitory glykogensyntázakinázy GSK-3
DK01928117T DK1286964T3 (da) 2000-05-11 2001-05-11 Heterocykliske inhibitorer glycogensynthasekinase GSK-3
EP01928117A EP1286964B1 (en) 2000-05-11 2001-05-11 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
ES01928117T ES2288948T3 (es) 2000-05-11 2001-05-11 Inhibidores heterociclicos del glicogeno sintasa quinasa gsk-3.
AU54981/01A AU783615B2 (en) 2000-05-11 2001-05-11 Heterocyclic inhibitors of glycogen synthase kinase GSK-3
KR1020027015132A KR100812407B1 (ko) 2000-05-11 2001-05-11 글리코겐 신타제 키나제 ｇｓｋ-3의 헤테로사이클릭 억제제
IL15272101A IL152721A0 (en) 2000-05-11 2001-05-11 Heterocyclic compounds and pharmaceutical compositions for inhibition of glycogen synthase kinase containing the same
SI200130744T SI1286964T1 (sl) 2000-05-11 2001-05-11 Heterocikliäťni inhibitorji glikogenske sintaze kinaze gsk-3
US10/290,569 US6872737B2 (en) 2000-05-11 2002-11-08 Heterocyclic inhibitors of glycogen synthase kinase GSK-3
US10/917,175 US7666885B2 (en) 2000-05-11 2004-08-12 Enzyme inhibitors
AU2006200668A AU2006200668B2 (en) 2000-05-11 2006-02-17 Heterocyclic inhibitors of glycogen synthase kinase GSK-3
US11/788,755 US7781463B2 (en) 2000-05-11 2007-04-20 Enzyme inhibitors
CY20071101111T CY1106826T1 (el) 2000-05-11 2007-08-30 Ετεροκυκλικοι αναστολεις της κινασης συνθασης γλυκογονου gsk-3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200001185A ES2166328B1 (es) 2000-05-11 2000-05-11 Inhibidores heterociclicos del enzima gsk 3 utiles en el tratamiento de procesos neurodegenerativos e hiperproliferativos

Publications (1)

Publication Number Publication Date
GB0030284D0 true GB0030284D0 (en) 2001-01-24

Family

ID=8493477

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0030284A Ceased GB0030284D0 (en) 2000-05-11 2000-12-12 Enzyme inhibitors

Country Status (5)

Country Link
JP (1) JP4897179B2 (https=)
CN (1) CN101045715B (https=)
ES (1) ES2166328B1 (https=)
GB (1) GB0030284D0 (https=)
PT (1) PT1286964E (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005024755A2 (en) * 2002-12-31 2005-03-17 Deciphera Pharmaceuticals, Llc. Medicaments for the treatment of neurodegenerative disorders or diabetes
EP1586318A1 (en) * 2004-04-05 2005-10-19 Neuropharma S.A.U. Thiadiazolidinones as GSK-3 inhibitors
US9180118B2 (en) * 2006-07-18 2015-11-10 University Of Rochester Thiadiazolidinone derivatives
AU2010270030B2 (en) * 2009-07-08 2015-12-24 Baltic Bio Ab 1, 2, 4-thiazolidin-3-one derivatives and their use in the treatment of cancer
ES2632428T3 (es) * 2012-02-24 2017-09-13 Asd Therapeutics Partners Llc Nuevas tiadiazolidinadionas como inhibidores de GSK-3
JP6649961B2 (ja) * 2015-03-17 2020-02-19 レゲネロン ファーマシューティカルス，インコーポレーテッド アミノ酸アシル化試薬及びその使用方法
CN105330608B (zh) * 2015-10-27 2018-06-26 南方科技大学 脲唑类轴手性化合物及其催化不对称合成方法
CN107151235B (zh) * 2016-03-04 2019-12-13 上海市计划生育科学研究所 噻二唑烷二酮基gsk3抑制剂在调节精子运动能力中的用途
GB201915094D0 (en) * 2019-10-18 2019-12-04 Balticgruppen Bio Ab New formulations
CN110698380B (zh) * 2019-10-24 2021-01-15 华东理工大学 一种内酰胺衍生物及其制备方法与应用
CN115197167B (zh) * 2022-07-22 2023-07-28 中国药科大学 1,2,4-噻二唑烷-3,5-二酮化合物及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2863803A (en) * 1957-05-13 1958-12-09 Stauffer Chemical Co Protecting materials against fungi by applying substituted dithiono and thiono-oxo-thiadiazolidines
US3301894A (en) * 1964-11-16 1967-01-31 Olin Mathieson S-[nu'-(chlorocarbonyl)-amino] isothiocarbamyl chlorides and their preparation
DE1670701A1 (de) * 1966-05-23 1970-11-12 Bayer Ag Verfahren zur Darstellung von Thiaimidazolidinen
US3900485A (en) * 1967-02-10 1975-08-19 Velsicol Chemical Corp New substituted 1,2,4-thiadiazolidine-3,5-diones
US3534057A (en) * 1968-05-28 1970-10-13 Velsicol Chemical Corp Halogenation process for the production of certain oxadiazolidines and thiadiazolidines
DE2109755A1 (de) * 1971-03-02 1972-09-07 Badische Anilin- & Soda-Fabrik Ag, 6700 Ludwigshafen Substituierte Thiadiazolidindione
JPS58216177A (ja) * 1982-06-10 1983-12-15 Sumitomo Chem Co Ltd フエニルチアジアゾリジンジオン誘導体、その製造法および該化合物を有効成分として含有する除草剤
ES2236702T3 (es) * 1993-12-23 2005-07-16 Eli Lilly And Company Inhibidores de la proteina quinasa c.
US5532256A (en) * 1994-05-18 1996-07-02 American Home Products Corporation New azolidinediones and thiadiazolidinediones as antihyperglycemic agents
DE4420522A1 (de) * 1994-06-13 1995-12-14 Bayer Ag Bakterizide Thiadiazolidinone
WO1997040017A2 (en) * 1996-04-19 1997-10-30 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
ATE284387T1 (de) * 1998-10-08 2004-12-15 Smithkline Beecham Plc 3-(3-chloro-4-hydroxyphenylamino)-4-(2- nitrophenyl)-1h-pyrrol-2,5-dion als glykogen synthase kinase-3 inhibitor (gsk-3)
GB9828640D0 (en) * 1998-12-23 1999-02-17 Smithkline Beecham Plc Novel method and compounds
GB9918180D0 (en) * 1999-08-02 1999-10-06 Smithkline Beecham Plc Novel compositions

Also Published As

Publication number Publication date
ES2166328A1 (es) 2002-04-01
ES2166328B1 (es) 2003-09-16
PT1286964E (pt) 2007-08-08
JP2003532708A (ja) 2003-11-05
CN101045715A (zh) 2007-10-03
JP4897179B2 (ja) 2012-03-14
CN101045715B (zh) 2010-11-24

Similar Documents

Publication Publication Date Title
AU2001258771A1 (en) -secretase inhibitors
IL146518A0 (en) Metalloprotease inhibitors
AU4344101A (en) Protease inhibitors
GB0017387D0 (en) Novel enzyme
GB0006733D0 (en) Enzyme
PL350452A1 (en) Dihetero-substituted metalloprotease inhibitors
AU2001236052A1 (en) Urease inhibitors
EP1307204A4 (en) PROTEASES INHIBITORS
GB0030284D0 (en) Enzyme inhibitors
EP1235577A4 (en) PROTEASE INHIBITORS
GB9924522D0 (en) Enzyme inhibitors
EP1232155A4 (en) PROTEASE INHIBITORS
EP1231921A4 (en) PROTEASE INHIBITORS
EP1229912A4 (en) PROTEASE INHIBITORS
EP1229915A4 (en) PROTEASE INHIBITORS
EP1229914A4 (en) PROTEASE INHIBITORS
EP1278502A4 (en) PROTEASE INHIBITORS
EP1233771A4 (en) PROTEASE INHIBITORS
EP1161237A4 (en) PROTEASE INHIBITORS
EP1351930A4 (en) PROTEASE INHIBITORS
EP1173429A4 (en) PROTEASE INHIBITORS
EP1229911A4 (en) PROTEASE INHIBITORS
EP1231923A4 (en) PROTEASE INHIBITORS
GB0229613D0 (en) Biocatalyst inhibitors
EP1232154A4 (en) PROTEASE INHIBITORS

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)